#USA #healthcare #Baltimore #Eli Lilly #Dave Ricks

Exploring the Future of Healthcare with Eli Lilly's CEO

The latest episode of "The Angle," a podcast produced by T. Rowe Price, features an insightful conversation with Dave Ricks, the Chair and Chief Executive Officer of Eli Lilly and Company. Renowned for its groundbreaking medical innovations, Eli Lilly stands out in sectors such as diabetes treatment, cancer care, and Alzheimer’s disease therapies, alongside its recent endeavors in the weight loss drug market.

In this episode, host Eric Veiel, T. Rowe Price's Head of Global Investments, invites Ricks to delve into the complexities of chronic disease management in a rapidly changing healthcare landscape. Ricks emphasizes the importance of purpose-driven leadership in addressing the pressing challenges facing the industry today. He articulates that effective healthcare solutions must not only be innovative but also accessible, ensuring that breakthroughs in medicine reach those who need them most.

Ricks reflects on Eli Lilly's commitment to fostering innovation and improving health outcomes globally. He identifies key challenges such as the rising incidence of chronic illnesses and the pressing need for effective management strategies. As healthcare continues to evolve, Ricks points out the necessity for companies to embrace transformative approaches that prioritize patient well-being.

"It was a privilege to sit down with Dave Ricks and explore his unique perspective on the future of healthcare," Veiel commented. "His insights into innovation, leadership, and the challenges of expanding access to transformative medicines are both timely and inspiring."

This episode marks the ninth installment of T. Rowe Price's C-suite podcast series, which has featured influential leaders from across various industries. Previous guests included executives from GE Aerospace, The New York Times Company, NVIDIA, and Citi, providing a diverse range of viewpoints on key issues shaping the business landscape today.

Listeners can access "The Angle" on various platforms, including Spotify and Apple Podcasts, where each episode promises to deliver essential insights into financial markets and investment strategies. The podcast aims to inspire investors by encouraging deeper understanding through engaging conversations and expert perspectives.

About T. Rowe Price

T. Rowe Price is a global asset management firm that manages approximately $1.79 trillion in client assets as of October 31, 2025. With an emphasis on integrity and client interests, the firm's mission is to empower investors and enhance their decision-making capabilities amidst fluctuating market conditions. Founded over 85 years ago, T. Rowe Price is celebrated for its commitment to excellence and independent research, continually asking challenging questions that lead to informed investment choices.

The insights shared by Ricks create a valuable roadmap for understanding the future of healthcare, as industry leaders face the dual challenges of innovation and equitable access. His vision encapsulates not just corporate responsibility, but a drive towards making a meaningful impact on global health outcomes.

Looking ahead, the healthcare industry stands at a crossroad where collaboration and innovation are pivotal for confronting the challenges of chronic disease management. The perspectives offered by Ricks in this podcast serve as a guide for leaders and investors alike, underscoring the undeniable link between purpose, leadership, and effective healthcare solutions.